(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736090 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EDNRB mRNA CTD PMID:22079256 (R)-noradrenaline multiple interactions ISO RGD:2536 6480464 [EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased secretion of Norepinephrine, [EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased secretion of Norepinephrine CTD PMID:16023617 (S)-colchicine increases expression ISO RGD:2536 6480464 Colchicine results in increased expression of EDNRB mRNA CTD PMID:20624997 (S)-nicotine increases activity ISO RGD:2536 6480464 Nicotine results in increased activity of EDNRB protein CTD PMID:21316381 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of EDNRB mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:736090 6480464 [Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of EDNRB mRNA CTD PMID:27344345 17beta-estradiol multiple interactions ISO RGD:736090 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EDNRB mRNA CTD PMID:20660070 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736090 6480464 Tetrachlorodibenzodioxin results in decreased expression of EDNRB mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2536 6480464 Tetrachlorodibenzodioxin affects the expression of EDNRB mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736090 6480464 Tetrachlorodibenzodioxin results in increased expression of EDNRB mRNA CTD PMID:25445724 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736090 6480464 AHR gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of EDNRB mRNA] CTD PMID:25445724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736090 6480464 Tetrachlorodibenzodioxin affects the expression of EDNRB mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EDNRB mRNA CTD PMID:19465110 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine multiple interactions ISO RGD:2536 6480464 EDNRB protein affects the reaction [Carbon Tetrachloride promotes the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor]], EDNRB protein affects the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor] CTD PMID:18205269 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of EDNRB mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:736090 6480464 Lactic Acid results in decreased expression of EDNRB mRNA CTD PMID:30851411 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:2536 6480464 Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDNRB mRNA] CTD PMID:7756592 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:2536 6480464 Puromycin Aminonucleoside results in increased expression of EDNRB mRNA CTD PMID:7756592 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of EDNRB mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:2536 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of EDNRB mRNA CTD PMID:30071829 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:2536 6480464 bisindolylmaleimide I inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein], bisindolylmaleimide I inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein] CTD PMID:15245872 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736090 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDNRB mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of EDNRB mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO RGD:2536 6480464 1, 2-dithiol-3-thione results in decreased expression of EDNRB mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol affects methylation ISO RGD:736090 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of EDNRB gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of EDNRB mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:736090 6480464 Fluorouracil results in decreased expression of EDNRB mRNA CTD PMID:24737281 6-propyl-2-thiouracil decreases expression ISO RGD:2536 6480464 Propylthiouracil results in decreased expression of EDNRB mRNA CTD PMID:24780913 6alpha-methylprednisolone multiple interactions ISO RGD:2536 6480464 Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of EDNRB mRNA] CTD PMID:7756592 7,12-dimethyltetraphene decreases expression ISO RGD:2536 6480464 9 more ... CTD PMID:19480007 7-NITROINDAZOLE multiple interactions ISO RGD:2536 6480464 7-nitroindazole inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein], 7-nitroindazole inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein] CTD PMID:15245872 8-bromo-3',5'-cyclic GMP multiple interactions ISO RGD:2536 6480464 8-bromocyclic GMP inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein], 8-bromocyclic GMP inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein] CTD PMID:16023617 acetamide increases expression ISO RGD:2536 6480464 acetamide results in increased expression of EDNRB mRNA CTD PMID:31881176 acetylsalicylic acid multiple interactions ISO RGD:736090 6480464 Aspirin inhibits the reaction [IL1B results in increased activity of EDNRB] CTD PMID:12126971 acrylamide decreases expression ISO RGD:2536 6480464 Acrylamide results in decreased expression of EDNRB mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:736090 6480464 Acrylamide results in decreased expression of EDNRB mRNA CTD PMID:32763439 actinomycin D multiple interactions ISO RGD:2536 6480464 Dactinomycin inhibits the reaction [Cyclosporine results in increased expression of EDNRB mRNA] more ... CTD PMID:20561571 more ... all-trans-retinoic acid decreases expression ISO RGD:736090 6480464 Tretinoin results in decreased expression of EDNRB mRNA CTD PMID:21934132 ammonium chloride affects expression ISO RGD:2536 6480464 Ammonium Chloride affects the expression of EDNRB mRNA CTD PMID:16483693 amphotericin B increases expression ISO RGD:736090 6480464 Amphotericin B results in increased expression of EDNRB mRNA CTD PMID:20849824 angiotensin II increases expression ISO RGD:2536 6480464 Angiotensin II results in increased expression of EDNRB protein CTD PMID:15007106 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:2536 6480464 pyrazolanthrone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA] more ... CTD PMID:20561571 more ... arsane decreases expression EXP 6480464 Arsenic results in decreased expression of EDNRB mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of EDNRB mRNA CTD PMID:19654921 arsenous acid decreases expression ISO RGD:736090 6480464 Arsenic Trioxide results in decreased expression of EDNRB mRNA CTD PMID:26705709 arsenous acid increases expression ISO RGD:736090 6480464 Arsenic Trioxide results in increased expression of EDNRB mRNA alternative form CTD PMID:19128835 atrasentan multiple interactions ISO RGD:2536 6480464 Atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA], Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of EDNRB mRNA] CTD PMID:18823320 , PMID:34102242 belinostat multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 belinostat increases expression ISO RGD:736090 6480464 belinostat results in increased expression of EDNRB mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EDNRB mRNA CTD PMID:22228805 , PMID:22610609 benzo[a]pyrene increases methylation ISO RGD:736090 6480464 Benzo(a)pyrene results in increased methylation of EDNRB exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:736090 6480464 Benzo(a)pyrene affects the methylation of EDNRB 5' UTR, Benzo(a)pyrene affects the methylation of EDNRB promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of EDNRB mRNA CTD PMID:19770486 more ... benzo[a]pyrene diol epoxide I affects expression ISO RGD:736090 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of EDNRB mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 bexarotene increases expression ISO RGD:2536 6480464 bexarotene results in increased expression of EDNRB mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2536 6480464 Diethylhexyl Phthalate results in increased expression of EDNRB mRNA CTD PMID:20920545 bisphenol A increases expression ISO RGD:2536 6480464 bisphenol A results in increased expression of EDNRB mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EDNRB mRNA CTD PMID:33221593 bisphenol A decreases expression ISO RGD:2536 6480464 bisphenol A results in decreased expression of EDNRB mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A multiple interactions ISO RGD:736090 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of EDNRB gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDNRB mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation ISO RGD:736090 6480464 bisphenol A results in increased methylation of EDNRB gene, bisphenol A results in increased methylation of EDNRB promoter CTD PMID:27271280 , PMID:31601247 bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of EDNRB mRNA CTD PMID:30951980 bosentan multiple interactions ISO RGD:736090 6480464 bosentan binds to and results in decreased activity of EDNRB protein CTD PMID:16219361 cadmium atom multiple interactions ISO RGD:736090 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EDNRB mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:736090 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EDNRB mRNA CTD PMID:35301059 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of EDNRB mRNA CTD PMID:12230499 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of EDNRB mRNA CTD PMID:23845593 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 celecoxib multiple interactions ISO RGD:2536 6480464 Celecoxib inhibits the reaction [BQ 788 results in decreased expression of EDNRB protein] more ... CTD PMID:24462674 , PMID:25656942 CGP 52608 multiple interactions ISO RGD:736090 6480464 CGP 52608 promotes the reaction [RORA protein binds to EDNRB gene] CTD PMID:28238834 chlorambucil increases mutagenesis EXP 6480464 Chlorambucil results in increased mutagenesis of EDNRB gene CTD PMID:10517996 chloroprene increases expression ISO RGD:2536 6480464 Chloroprene results in increased expression of EDNRB mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:2536 6480464 Chlorpyrifos results in decreased expression of EDNRB mRNA CTD PMID:20691718 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EDNRB mRNA CTD PMID:20938992 chromium atom multiple interactions EXP 6480464 LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] CTD PMID:16940432 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 cisplatin increases expression ISO RGD:736090 6480464 Cisplatin results in increased expression of EDNRB mRNA CTD PMID:20849824 cocaine affects expression ISO RGD:2536 6480464 Cocaine affects the expression of EDNRB mRNA CTD PMID:20187946 copper atom increases expression ISO RGD:2536 6480464 Copper results in increased expression of EDNRB mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:2536 6480464 Copper results in increased expression of EDNRB mRNA CTD PMID:30556269 Cuprizon increases expression ISO RGD:2536 6480464 Cuprizone results in increased expression of EDNRB mRNA CTD PMID:26577399 , PMID:27523638 cycloheximide multiple interactions ISO RGD:2536 6480464 Cycloheximide inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA] more ... CTD PMID:20561571 , PMID:20716444 cyclophosphamide increases expression ISO RGD:736090 6480464 Cyclophosphamide results in increased expression of EDNRB mRNA CTD PMID:20849824 cyclosporin A multiple interactions ISO RGD:2536 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Cyclosporine results in increased expression of EDNRB mRNA] more ... CTD PMID:24462674 more ... cyclosporin A increases expression ISO RGD:2536 6480464 Cyclosporine results in increased expression of EDNRB mRNA, Cyclosporine results in increased expression of EDNRB protein CTD PMID:25772258 cyclosporin A decreases expression ISO RGD:2536 6480464 Cyclosporine results in decreased expression of EDNRB protein CTD PMID:24462674 , PMID:25656942 daunorubicin increases expression ISO RGD:2536 6480464 Daunorubicin results in increased expression of EDNRB protein CTD PMID:20888384 daunorubicin multiple interactions ISO RGD:2536 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of EDNRB protein] CTD PMID:20888384 dexamethasone multiple interactions ISO RGD:2536 6480464 Dexamethasone promotes the reaction [nitrofen results in increased expression of EDNRB mRNA] CTD PMID:10693666 dexamethasone multiple interactions ISO RGD:736090 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDNRB mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of EDNRB mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:736090 6480464 Arsenic Trioxide results in decreased expression of EDNRB mRNA CTD PMID:26705709 diarsenic trioxide increases expression ISO RGD:736090 6480464 Arsenic Trioxide results in increased expression of EDNRB mRNA alternative form CTD PMID:19128835 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of EDNRB mRNA CTD PMID:17361019 , PMID:21266533 dimethyl sulfoxide increases expression ISO RGD:2536 6480464 Dimethyl Sulfoxide results in increased expression of EDNRB mRNA, Dimethyl Sulfoxide results in increased expression of EDNRB protein CTD PMID:20561571 dimethyl sulfoxide multiple interactions ISO RGD:2536 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA] more ... CTD PMID:20561571 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of EDNRB mRNA more ... CTD PMID:21926265 , PMID:25203536 dioxygen decreases methylation ISO RGD:2536 6480464 Oxygen deficiency results in decreased methylation of EDNRB promoter CTD PMID:34478853 dioxygen increases expression ISO RGD:2536 6480464 Oxygen deficiency results in increased expression of EDNRB mRNA, Oxygen deficiency results in increased expression of EDNRB protein CTD PMID:34478853 dioxygen decreases expression ISO RGD:2536 6480464 Oxygen deficiency results in decreased expression of EDNRB protein CTD PMID:28985491 dioxygen multiple interactions ISO RGD:2536 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EDNRB mRNA, tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of EDNRB protein] CTD PMID:28985491 , PMID:33729688 dioxygen increases expression ISO RGD:736090 6480464 Oxygen deficiency results in increased expression of EDNRB mRNA CTD PMID:24236059 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDNRB mRNA more ... CTD PMID:21926265 , PMID:30529165 dorsomorphin multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression ISO RGD:2536 6480464 Endosulfan results in increased expression of EDNRB mRNA CTD PMID:29391264 endosulfan decreases expression ISO RGD:2536 6480464 Endosulfan results in decreased expression of EDNRB mRNA CTD PMID:31464424 enrasentan multiple interactions ISO RGD:736090 6480464 enrasentan binds to and results in decreased activity of EDNRB protein CTD PMID:16219361 entinostat multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:736090 6480464 entinostat results in increased expression of EDNRB mRNA CTD PMID:26272509 ethanol decreases expression ISO RGD:2536 6480464 Ethanol results in decreased expression of EDNRB protein CTD PMID:16651399 ethanol increases expression ISO RGD:736090 6480464 Ethanol results in increased expression of EDNRB mRNA CTD PMID:31059573 ethanol increases expression EXP 6480464 Ethanol results in increased expression of EDNRB mRNA CTD PMID:30319688 etoposide decreases expression EXP 6480464 Etoposide results in decreased expression of EDNRB mRNA CTD PMID:25270620 fenoterol increases expression ISO RGD:736090 6480464 Fenoterol results in increased expression of EDNRB mRNA CTD PMID:16340002 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EDNRB mRNA CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of EDNRB mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:736090 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of EDNRB gene CTD PMID:31601247 gefitinib multiple interactions EXP 6480464 gefitinib inhibits the reaction [TGFA protein results in decreased expression of EDNRB mRNA] CTD PMID:18424623 genistein decreases expression EXP 6480464 Genistein results in decreased expression of EDNRB mRNA CTD PMID:32186404 gentamycin multiple interactions ISO RGD:2536 6480464 [Gentamicins results in increased expression of EDNRB protein] which results in increased abundance of Nitrites CTD PMID:15200423 gentamycin increases expression ISO RGD:736090 6480464 Gentamicins results in increased expression of EDNRB mRNA CTD PMID:20849824 gentamycin increases expression ISO RGD:2536 6480464 Gentamicins results in increased expression of EDNRB protein CTD PMID:15200423 hydrogen cyanide increases expression EXP 6480464 Hydrogen Cyanide results in increased expression of EDNRB mRNA CTD PMID:33914522 Ile(5)-angiotensin II increases expression ISO RGD:2536 6480464 Angiotensin II results in increased expression of EDNRB protein CTD PMID:15007106 indometacin multiple interactions ISO RGD:736090 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EDNRB mRNA more ... CTD PMID:12126971 , PMID:28628672 isoprenaline multiple interactions ISO RGD:2536 6480464 CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRB mRNA], natakalim inhibits the reaction [Isoproterenol results in increased expression of EDNRB protein] CTD PMID:18594475 , PMID:27174236 isoprenaline increases expression ISO RGD:2536 6480464 Isoproterenol results in increased expression of EDNRB mRNA, Isoproterenol results in increased expression of EDNRB protein CTD PMID:18594475 , PMID:27174236 isoquinoline-1,5-diol decreases expression ISO RGD:2536 6480464 1, 5-dihydroxyisoquinoline results in decreased expression of EDNRB mRNA CTD PMID:12824290 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of EDNRB mRNA CTD PMID:15305145 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EDNRB mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:736090 6480464 lead acetate results in increased expression of EDNRB mRNA CTD PMID:22839698 mercury dibromide increases expression ISO RGD:736090 6480464 mercuric bromide results in increased expression of EDNRB mRNA CTD PMID:26272509 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of EDNRB mRNA CTD PMID:18502557 methylmercury chloride increases expression ISO RGD:736090 6480464 methylmercuric chloride results in increased expression of EDNRB mRNA CTD PMID:34089799 methylseleninic acid increases expression ISO RGD:736090 6480464 methylselenic acid results in increased expression of EDNRB mRNA CTD PMID:18548127 mifepristone increases expression ISO RGD:736090 6480464 Mifepristone results in increased expression of EDNRB mRNA CTD PMID:17584828 MK-2206 increases expression ISO RGD:736090 6480464 MK 2206 results in increased expression of EDNRB protein CTD PMID:34398343 MK-2206 multiple interactions ISO RGD:736090 6480464 MK 2206 inhibits the reaction [RARRES2 protein results in decreased expression of EDNRB protein modified form] CTD PMID:34398343 N(gamma)-nitro-L-arginine methyl ester decreases expression ISO RGD:2536 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of EDNRB mRNA CTD PMID:34102242 N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO RGD:2536 6480464 Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of EDNRB mRNA] CTD PMID:34102242 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:2536 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in increased activity of NOS1 protein] CTD PMID:15245872 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions ISO RGD:2536 6480464 N-(3 more ... CTD PMID:18718921 , PMID:22207076 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of EDNRB gene CTD PMID:17174358 , PMID:9475716 N-methyl-N-nitrosourea increases mutagenesis EXP 6480464 Methylnitrosourea results in increased mutagenesis of EDNRB gene CTD PMID:17174358 N-nitrosodiethylamine increases expression ISO RGD:2536 6480464 Diethylnitrosamine results in increased expression of EDNRB mRNA CTD PMID:19638242 nicotine increases activity ISO RGD:2536 6480464 Nicotine results in increased activity of EDNRB protein CTD PMID:21316381 nicotinic acid multiple interactions EXP 6480464 LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] CTD PMID:16940432 nimesulide multiple interactions ISO RGD:736090 6480464 nimesulide inhibits the reaction [IL1B results in increased activity of EDNRB] CTD PMID:12126971 nitric oxide multiple interactions ISO RGD:2536 6480464 [EDN1 protein results in increased activity of EDNRB protein] which results in increased abundance of Nitric Oxide CTD PMID:16380457 nitrites multiple interactions ISO RGD:2536 6480464 [Gentamicins results in increased expression of EDNRB protein] which results in increased abundance of Nitrites CTD PMID:15200423 nitrofen increases expression ISO RGD:2536 6480464 nitrofen results in increased expression of EDNRB mRNA, nitrofen results in increased expression of EDNRB protein CTD PMID:10693666 , PMID:19851775 nitrofen multiple interactions ISO RGD:2536 6480464 Dexamethasone promotes the reaction [nitrofen results in increased expression of EDNRB mRNA] CTD PMID:10693666 nitroprusside multiple interactions ISO RGD:2536 6480464 Nitroprusside inhibits the reaction [[EDN1 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein], Nitroprusside inhibits the reaction [[EDN3 protein binds to and results in increased activity of EDNRB protein] which results in decreased activity of TH protein] CTD PMID:16023617 Nonylphenol increases expression ISO RGD:2536 6480464 nonylphenol results in increased expression of EDNRB mRNA CTD PMID:15620428 ozone multiple interactions ISO RGD:2536 6480464 [Ozone co-treated with Vehicle Emissions] results in increased expression of EDNRB mRNA CTD PMID:20980218 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EDNRB mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of EDNRB mRNA CTD PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of EDNRB mRNA CTD PMID:31626304 ozone increases expression ISO RGD:2536 6480464 Ozone results in increased expression of EDNRB mRNA CTD PMID:16081523 , PMID:20980218 panobinostat multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:736090 6480464 panobinostat results in increased expression of EDNRB mRNA CTD PMID:26272509 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of EDNRB mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:736090 6480464 Acetaminophen results in decreased expression of EDNRB mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:736090 6480464 Acetaminophen results in increased expression of EDNRB mRNA CTD PMID:21420995 paricalcitol multiple interactions ISO RGD:736090 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of EDNRB mRNA CTD PMID:17715259 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of EDNRB mRNA CTD PMID:23091169 phenylephrine increases expression ISO RGD:2536 6480464 Phenylephrine results in increased expression of EDNRB protein CTD PMID:15007106 phenylmercury acetate increases expression ISO RGD:736090 6480464 Phenylmercuric Acetate results in increased expression of EDNRB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 phosphoramidon increases expression ISO RGD:2536 6480464 phosphoramidon results in increased expression of EDNRB protein CTD PMID:15007106 phosphorus atom multiple interactions ISO RGD:736090 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of EDNRB mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:736090 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of EDNRB mRNA CTD PMID:17715259 picrotoxin decreases expression ISO RGD:2536 6480464 Picrotoxin results in decreased expression of EDNRB mRNA CTD PMID:15170462 potassium chloride multiple interactions ISO RGD:2536 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA, atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA] CTD PMID:18823320 potassium chromate multiple interactions ISO RGD:736090 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EDNRB mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:736090 6480464 potassium chromate(VI) results in decreased expression of EDNRB mRNA CTD PMID:22079256 potassium cyanide increases expression EXP 6480464 Potassium Cyanide results in increased expression of EDNRB mRNA CTD PMID:33914522 progesterone multiple interactions ISO RGD:736090 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EDNRB mRNA CTD PMID:20660070 progesterone increases expression ISO RGD:736090 6480464 Progesterone results in increased expression of EDNRB mRNA CTD PMID:21540246 quercetin increases expression ISO RGD:736090 6480464 Quercetin results in increased expression of EDNRB mRNA CTD PMID:15309432 quercetin affects expression ISO RGD:2536 6480464 Quercetin affects the expression of EDNRB mRNA CTD PMID:18178720 rac-lactic acid decreases expression ISO RGD:736090 6480464 Lactic Acid results in decreased expression of EDNRB mRNA CTD PMID:30851411 rofecoxib multiple interactions ISO RGD:736090 6480464 rofecoxib inhibits the reaction [IL1B results in increased activity of EDNRB] CTD PMID:12126971 SB 203580 multiple interactions ISO RGD:2536 6480464 SB 203580 inhibits the reaction [Cyclosporine results in increased expression of EDNRB mRNA] more ... CTD PMID:18718921 more ... SB 431542 multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SB-239063 multiple interactions ISO RGD:2536 6480464 SB 239063 inhibits the reaction [Smoke results in increased expression of EDNRB mRNA], SB 239063 inhibits the reaction [Smoke results in increased expression of EDNRB protein] CTD PMID:18718921 serpentine asbestos increases methylation ISO RGD:736090 6480464 Asbestos, Serpentine results in increased methylation of EDNRB 5' UTR CTD PMID:29523930 sodium arsenite increases expression ISO RGD:736090 6480464 sodium arsenite results in increased expression of EDNRB mRNA CTD PMID:20371982 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of EDNRB mRNA CTD PMID:32068019 sodium arsenite multiple interactions ISO RGD:736090 6480464 sodium arsenite inhibits the reaction [EDN1 protein results in increased expression of EDNRB] CTD PMID:28470405 sodium chloride multiple interactions ISO RGD:2536 6480464 [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA, atrasentan inhibits the reaction [[19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA] CTD PMID:18823320 sorafenib increases expression ISO RGD:2536 6480464 Sorafenib results in increased expression of EDNRB mRNA, Sorafenib results in increased expression of EDNRB protein CTD PMID:33503445 staurosporine multiple interactions ISO RGD:2536 6480464 Staurosporine inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA], Staurosporine inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein] CTD PMID:20561571 Tanshinone I multiple interactions ISO RGD:2536 6480464 tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of EDNRB protein] CTD PMID:28985491 telmisartan multiple interactions ISO RGD:2536 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of EDNRB protein] CTD PMID:20888384 testosterone affects expression ISO RGD:2536 6480464 Testosterone affects the expression of EDNRB mRNA CTD PMID:12122504 , PMID:14616470 testosterone enanthate affects expression ISO RGD:736090 6480464 testosterone enanthate affects the expression of EDNRB mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of EDNRB mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of EDNRB mRNA CTD PMID:29987408 tetrachloromethane multiple interactions ISO RGD:2536 6480464 EDNRB protein affects the reaction [Carbon Tetrachloride promotes the reaction [EDN1 protein results in increased abundance of Platelet Activating Factor]] CTD PMID:18205269 tetrachloromethane increases expression ISO RGD:2536 6480464 Carbon Tetrachloride results in increased expression of EDNRB mRNA, Carbon Tetrachloride results in increased expression of EDNRB protein CTD PMID:12708965 more ... tetrachloromethane increases activity ISO RGD:2536 6480464 Carbon Tetrachloride results in increased activity of EDNRB protein CTD PMID:12873816 tetrachloromethane decreases expression ISO RGD:2536 6480464 Carbon Tetrachloride results in decreased expression of EDNRB mRNA CTD PMID:16644059 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA CTD PMID:27858113 thimerosal decreases expression ISO RGD:736090 6480464 Thimerosal results in decreased expression of EDNRB mRNA CTD PMID:27188386 thioacetamide increases expression ISO RGD:2536 6480464 Thioacetamide results in increased expression of EDNRB mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of EDNRB mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of EDNRB mRNA CTD PMID:29264374 trichloroethene increases expression ISO RGD:2536 6480464 Trichloroethylene results in increased expression of EDNRB mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736090 6480464 trichostatin A results in increased expression of EDNRB mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of EDNRB mRNA CTD PMID:28973697 U-73122 multiple interactions ISO RGD:2536 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:15245872 udenafil decreases expression ISO RGD:2536 6480464 udenafil results in decreased expression of EDNRB CTD PMID:21366883 urethane multiple interactions EXP 6480464 Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of EDNRB mRNA], IFNG protein inhibits the reaction [Urethane results in decreased expression of EDNRB mRNA] CTD PMID:12810352 urethane decreases expression EXP 6480464 Urethane results in decreased expression of EDNRB mRNA CTD PMID:12810352 valproic acid affects expression ISO RGD:736090 6480464 Valproic Acid affects the expression of EDNRB mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:736090 6480464 Valproic Acid results in increased expression of EDNRB mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 venlafaxine hydrochloride increases expression ISO RGD:2536 6480464 Venlafaxine Hydrochloride results in increased expression of EDNRB mRNA CTD PMID:25423262 vincaleukoblastine increases expression ISO RGD:2536 6480464 Vinblastine results in increased expression of EDNRB mRNA CTD PMID:20624997 vincristine increases expression ISO RGD:2536 6480464 Vincristine results in increased expression of EDNRB mRNA CTD PMID:20624997 vorinostat multiple interactions ISO RGD:736090 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDNRB mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:736090 6480464 vorinostat results in increased expression of EDNRB mRNA CTD PMID:26272509 wedelolactone multiple interactions ISO RGD:2536 6480464 wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA] more ... CTD PMID:18718921 more ... zinc atom decreases expression ISO RGD:2536 6480464 Zinc results in decreased expression of EDNRB mRNA CTD PMID:17074742 zinc sulfate decreases expression ISO RGD:2536 6480464 Zinc Sulfate results in decreased expression of EDNRB mRNA CTD PMID:17074742 zinc(0) decreases expression ISO RGD:2536 6480464 Zinc results in decreased expression of EDNRB mRNA CTD PMID:17074742